Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Multiple Myeloma 7Breast Neoplasms 6Neoplasms, Plasma Cell 5Neoplasm Metastasis 3Pain 2Spondylitis, Ankylosing 1Prostatic Neoplasms 1Bone Diseases 1

Interventions

pembrolizumab 156Gemcitabine 140Capecitabine 123Paclitaxel 120Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Leucovorin 97Docetaxel 97Cisplatin 89Radiosurgery 88Irinotecan 87Carboplatin 85Cetuximab 72Cyclophosphamide 71Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Pamidronate × Clear all
NCT00128297 2023-03-28

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Spanish Breast Cancer Research Group

Phase 4 Completed
152 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02721433 2020-12-02

REaCT-BTA

Ottawa Hospital Research Institute

Phase 4 Completed
263 enrolled
BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

HaEmek Medical Center, Israel

Phase 2 Terminated
22 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡